Question 1

What is a 'research peptide'?

Accepted Answer

An informal term used by suppliers for peptides sold without a marketing authorisation for human use, typically labelled 'research use only' or 'not for human consumption'. It does not mean the peptide has been tested for human safety or efficacy.

Question 2

Are 'research peptides' the same as licensed medicines?

Accepted Answer

No. A licensed medicine has been through regulatory review for safety, efficacy, and quality. A 'research peptide' has not. Even when the molecule is the same, the supply chain, quality control, and human safety evidence are different.

Question 3

What does 'not for human consumption' mean?

Accepted Answer

It is the seller's statement that the product is not being sold as food or medicine. It does not mean the product is automatically safer, or that selling it for human use is automatically lawful — UK regulators consider context and intended purpose.

Question 4

How is the evidence for a 'research peptide' typically described?

Accepted Answer

Often as 'preclinical' — animal models, cell cultures, or theoretical mechanism. Robust human RCTs are usually lacking. We label this with our public evidence grading (typically D or E for these compounds).

Question 5

Are animal studies enough to show a peptide works in humans?

Accepted Answer

No. Many promising preclinical results do not translate to humans. Animal studies are useful for hypothesis-generation and mechanism, not for clinical decisions.

Question 6

Are 'research peptides' tested for purity?

Accepted Answer

Some sellers publish certificates of analysis. These can be falsified, can refer to a different batch from the one shipped, or can measure identity without addressing sterility, endotoxin, or impurity profile. They are not a substitute for regulated supply.

Question 7

What contamination risks come with grey-market peptides?

Accepted Answer

Process impurities, residual solvents, bacterial endotoxins, mis-identification, mis-labelled strength, and undisclosed active ingredients have all been documented in independent testing of grey-market peptide samples.

Question 8

Why are 'research peptides' a particular risk for athletes?

Accepted Answer

WADA's S0 'non-approved substances' category captures most unlicensed peptides. Strict liability means contamination of an unrelated supplement could still cause a positive test. There is no 'this peptide is fine because no test exists' position.

Question 9

Can a clinic prescribe 'research peptides'?

Accepted Answer

A clinic offering an unlicensed compound as a 'therapy' faces both regulatory and clinical-governance issues. There is no UK licence to prescribe under, no Patient Information Leaflet, and no licensed indication. See /safety-centre/clinic-claim-red-flags.

Question 10

Is BPC-157 a 'research peptide'?

Accepted Answer

Commercially, yes — it is widely sold under that label. It is not a licensed UK medicine for any indication. Robust human evidence is lacking; the literature is mostly preclinical.

Question 11

Are cosmetic peptides 'research peptides'?

Accepted Answer

No. Topical cosmetic peptides (Matrixyl, Argireline, copper peptides, palmitoyl tripeptides) are regulated under UK cosmetics legislation. Their permitted claims are constrained but they are a separate category from injectable 'research peptides'.

Question 12

What should I ask a doctor about a 'research peptide' I'm considering?

Accepted Answer

Is it licensed for any condition? What does the human evidence look like? Are there interactions with my current medicines? What are the worst-case adverse events? Is there a licensed alternative? What is the WADA status?

Research peptides — UK frequently asked questions

Related

Research peptides — UK frequently asked questions

Related